Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.

Cao, K I; Lebas, N; Gerber, S; Levy, C; Le Scodan, R; Bourgier, C; Pierga, J-Y; Gobillion, A; Savignoni, A; Kirova, Y M

Cao, K I; Lebas, N; Gerber, S; Levy, C; Le Scodan, R; Bourgier, C; Pierga, J-Y; Gobillion, A; Savignoni, A; Kirova, Y M.

Affiliation

Cao KI; Department of Radiation Oncology.
Lebas N; Department of Statistics.
Gerber S; Department of Radiology, Institut Curie, Paris.
Levy C; Department of Radiation Oncology, Centre François Baclesse, Caen.
Le Scodan R; Department of Radiation Oncology.
Bourgier C; Department of Radiation Oncology, Institut Gustave Roussy, Villejuif.
Pierga JY; Department of Medical Oncology, Institut Curie, Paris, France.
Gobillion A; Department of Statistics.
Savignoni A; Department of Statistics.
Kirova YM; Department of Radiation Oncology. Electronic address: youlia.kirova@curie.fr.

Ann Oncol ; 26(1): 89-94, 2015 Jan.

Article in En | MEDLINE | ID: mdl-25355723

Subject(s)

Antineoplastic Agents, Alkylating/therapeutic use; Brain Neoplasms/radiotherapy; Breast Neoplasms/pathology; Dacarbazine/analogs & derivatives; Adult; Aged; Brain Neoplasms/secondary; Combined Modality Therapy; Cranial Irradiation; Dacarbazine/therapeutic use; Disease-Free Survival; Female; Humans; Middle Aged; Prospective Studies; Temozolomide

Key words

brain metastases; metastatic breast cancer; temozolomide; whole-brain radiation therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms / Antineoplastic Agents, Alkylating / Dacarbazine Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google